Webinar Replay: MedTech CDMO: Market and M&A Trends in the U.S. in 2023

Watch Now On-Demand

2023 is expected to exhibit fundamental trends affecting the manufacturing industry in the post-COVID era, where just like in 2022 the availability of device components and skilled labor remain scarce.

The medical device industry is faced with growing challenges from the unpredictability of the demand to components, product shortages and bottlenecks to sterilization and logistics. In this environment, contract development and manufacturing organizations carry a growing responsibility to fulfill the needs of medical care operators.

Watch this webinar hosted by MassMEDIC to discover the current trends shaping the US medical device outsourcing landscape, with a particular focus on its performance and business outlook, and sustained M&A activity.

Our Speaker:
Published on:
March 24, 2023
Carlo Stimamiglio

Carlo Stimamiglio

Partner, Transaction Advisory Services, Alira Health Carlo engages with Alira Health’s strategy consulting and M&A mandates for medical devices, capital equipment, and pharmaceutical companies in the U.S. and Europe. Prior to joining Alira Health, Carlo worked at a multi-billion Italian asset management firm and later joined an investment banking boutique, where he advised mid-market private equity firms in various international transactions. Carlo holds an MS in Finance from the University of Verona and an MBA from IE Business School.

Download the full “The 2023 U.S. MedTech Contract Manufacturing Report” to learn more about the latest industry trends and their meaning for medical device CDMOs and their capital sponsors, providing insight into the market trends with a critical view of the opportunities and risks that lie ahead.


Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.